1. Wu, Junlu, Chen, Guofei, Wang, Weiwei, Quan, Wenqiang, Wang, Lixin. 2022. GTPBP4: A New Therapeutic Target Gene Promotes Tumor Progression in Non-Small Cell Lung Cancer via EMT. In Journal of oncology, 2022, 2164897. doi:10.1155/2022/2164897. https://pubmed.ncbi.nlm.nih.gov/36405249/
2. Zhou, Qiang, Yin, Yirui, Yu, Mincheng, Zhou, Chenhao, Ren, Ning. 2022. GTPBP4 promotes hepatocellular carcinoma progression and metastasis via the PKM2 dependent glucose metabolism. In Redox biology, 56, 102458. doi:10.1016/j.redox.2022.102458. https://pubmed.ncbi.nlm.nih.gov/36116159/
3. Yu, Haitao, Jin, Sufeng, Zhang, Na, Xu, Qi. 2016. Up-regulation of GTPBP4 in colorectal carcinoma is responsible for tumor metastasis. In Biochemical and biophysical research communications, 480, 48-54. doi:10.1016/j.bbrc.2016.10.010. https://pubmed.ncbi.nlm.nih.gov/27720713/
4. Hu, Yiming, Xie, Jiaheng, Chen, Liang, Yin, Lu, Ji, Jing. 2022. Integrated Analysis of Genomic and Transcriptomic Profiles Identified the Role of GTP Binding Protein-4 (GTPBP4) in Breast Cancer. In Frontiers in pharmacology, 13, 880445. doi:10.3389/fphar.2022.880445. https://pubmed.ncbi.nlm.nih.gov/35784753/